Answers are grounded in this paper and cite their sources.
Observational analysis showed improved coat condition and health parameters in horses with hypertrichosis, suggesting blue light could aid treatment of PPID.
Fifty-two horses aged >15 years, diagnosed with pituitary pars intermedia dysfunction (PPID), and displaying hypertrichosis were recruited via an online survey of PPID horse owners. From mid-December, group T wore Equilume® light masks extending photoperiod to 15 hours daily (n=29), while group C1 (n=23) and a second unmedicated PPID research herd (C2; n=17) remained under natural photoperiod. Hair lengths, shedding and body condition scores were assessed monthly for 13 months. Data related to management, coat condition and PPID clinical signs were collected using bimonthly questionnaires (BMQ). Time (p< 0.001), group (p=0.025) and time-by-group interaction (p=0.005) affected hair length. Group differences were attributable to shorter hair lengths in C2, and no differences in hair length occurred between T and C1 (p>0.05). Time affected shedding scores (p< 0.001) which was advanced by one month in T (p< 0.05). In group T, BMQ responses showed improved coat condition in April (p=0.035), decreased fat coverage in April and June (p< 0.05), and increased energy/alertness in February (p=0.022). Improvements in coat condition (p=0.043), clinical signs of PPID (p=0.018), and general quality of life (p=0.035) were reported in T only in a final study questionnaire. Blue light treatment merits further investigation as a complementary treatment for PPID.
No takes yet. Share an insight, caveat, or question.
Parmantier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: